Home › Colorectal Cancer
Pag-aaral pangklinika para sa Colorectal Cancer na nagre-recruit sa U.S.
332 pag-aaral para sa Colorectal Cancer ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX101 pag-aaral
- New York City, NY86 pag-aaral
- Nashville, TN67 pag-aaral
- Boston, MA62 pag-aaral
- Los Angeles, CA61 pag-aaral
- Arlington, VA54 pag-aaral
- St. Louis, MO51 pag-aaral
- San Antonio, TX43 pag-aaral
- Philadelphia, PA41 pag-aaral
- Grand Rapids, MI40 pag-aaral
- Baldwin Park, CA37 pag-aaral
- Tampa, FL36 pag-aaral
- Seattle, WA35 pag-aaral
- Dallas, TX34 pag-aaral
- Queens, NY33 pag-aaral
- Aurora, CO33 pag-aaral
- Chicago, IL32 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Durham, NC30 pag-aaral
- Baltimore, MD30 pag-aaral
- Atlanta, GA29 pag-aaral
- Portland, OR28 pag-aaral
- Washington, DC28 pag-aaral
- Rochester, MN27 pag-aaral
- Detroit, MI25 pag-aaral
- Edison, NJ25 pag-aaral
- Cleveland, OH25 pag-aaral
- Jacksonville, FL25 pag-aaral
- Phoenix, AZ24 pag-aaral
- Columbus, OH24 pag-aaral
- New Haven, CT23 pag-aaral
- Ann Arbor, MI22 pag-aaral
- Salt Lake City, UT22 pag-aaral
- San Diego, CA22 pag-aaral
- Madison, WI22 pag-aaral
- Oklahoma City, OK22 pag-aaral
- Denver, CO22 pag-aaral
- Orlando, FL21 pag-aaral
- Cincinnati, OH20 pag-aaral
- Minneapolis, MN20 pag-aaral
Ayos sa estado
- Alabama11 pag-aaral
- Alaska4 pag-aaral
- Arizona55 pag-aaral
- Arkansas14 pag-aaral
- California135 pag-aaral
- Colorado55 pag-aaral
- Connecticut27 pag-aaral
- Delaware9 pag-aaral
- District of Columbia16 pag-aaral
- Florida99 pag-aaral
- Georgia38 pag-aaral
- Hawaii5 pag-aaral
- Idaho7 pag-aaral
- Illinois49 pag-aaral
- Indiana24 pag-aaral
- Iowa15 pag-aaral
- Kansas18 pag-aaral
- Kentucky19 pag-aaral
- Louisiana17 pag-aaral
- Maine4 pag-aaral
- Maryland45 pag-aaral
- Massachusetts62 pag-aaral
- Michigan70 pag-aaral
- Minnesota44 pag-aaral
- Mississippi6 pag-aaral
- Missouri59 pag-aaral
- Montana6 pag-aaral
- Nebraska22 pag-aaral
- Nevada10 pag-aaral
- New Hampshire6 pag-aaral
- New Jersey38 pag-aaral
- New Mexico8 pag-aaral
- New York103 pag-aaral
- North Carolina47 pag-aaral
- North Dakota7 pag-aaral
- Ohio62 pag-aaral
- Oklahoma22 pag-aaral
- Oregon28 pag-aaral
- Pennsylvania66 pag-aaral
- Rhode Island5 pag-aaral
- South Carolina14 pag-aaral
- South Dakota12 pag-aaral
- Tennessee74 pag-aaral
- Texas145 pag-aaral
- Utah35 pag-aaral
- Vermont5 pag-aaral
- Virginia77 pag-aaral
- Washington48 pag-aaral
- West Virginia6 pag-aaral
- Wisconsin35 pag-aaral
- Wyoming3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07693751Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
Nagre-recruit
Edad 22 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07276529Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06959550Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Nob 12, 2026 · NCT05649072Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07750158Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04847063Evaluation for NCI Surgery Branch Clinical Research Protocols
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00001823Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06878131A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07659795Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07500298A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06270706A KRAS Inhibitor in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07912593Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 72 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01174121Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07775287A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07458347A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06004245Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04739072A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07020221Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT04557449A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07503808Role of Diet on the Microbiome of the Digestive System
Nagre-recruitObservasyonal na pag-aaral
Edad 45 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT04666727Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06102902Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
Nagre-recruitPhase 1/2May bayad para sa mga kalahok
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06149481Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT04222413A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT04929223Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.